Treatment of behavioral disorders with .beta.-lactam compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6627625
SERIAL NO

09640363

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Administration of .beta.-lactam compounds including .beta.-lactam antibiotics and .beta.-lactamase inhibitors provides significant neurotropic effects in warm-blooded vertebrates evidenced inter alia by anxiolytic and anti-aggressive behavior modification and enhanced cognition. Therapeutic methods for using such compounds and their pharmaceutical formulations are described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
REVAAX PHARMACEUTICALS LLCP O BOX 22476 INDIANPOLIS IN 46222

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Koppel, Gary A Indianapolis, IN 50 497

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation